ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CEACAM1Antibody Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-31N12311
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global CEACAM1Antibody Market Research Report 2022
BUY CHAPTERS

Global CEACAM1Antibody Market Research Report 2024

Code: QYRE-Auto-31N12311
Report
April 2024
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bio-Techne
BioLegend
Lifespan Biosciences Inc.
Elabscience Biotechnology Inc.
Wuhan Fine Biotech Co.,Ltd.
ProSci Incorporated
Abbexa
Boster Biological Technology
Merck
Sino Biological Inc
Thermo Fisher Scientific (China) Co., Ltd.
Abcam

CEACAM1Antibody Market Size

The global CEACAM1Antibody market was valued at US$ 394.6 million in 2023 and is anticipated to reach US$ 894.4 million by 2030, witnessing a CAGR of 12.4% during the forecast period 2024-2030.

CEACAM1Antibody Market

CEACAM1Antibody Market

CEACAM1 Antibody is a specific antibody for detecting and studying CEACAM1 protein (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1).
CEACAM1 is a cell adhesion molecule belonging to the CEA family that is widely distributed on the surface of many cell types, including epithelial cells, leukocytes, and immune cells. It plays an important role in biological processes such as cell adhesion, immune regulation, and tumor development. CEACAM1 antibody can be used to study the expression, distribution and relationship of CEACAM1 with cell signal transduction, adhesion, immune regulation, etc., which will help to understand the function of CEACAM1 in cell biology and disease mechanism. In addition, it may also have potential applications in cancer diagnosis and treatment research.
This report aims to provide a comprehensive presentation of the global market for CEACAM1Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CEACAM1Antibody.

Report Scope

The CEACAM1Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CEACAM1Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CEACAM1Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CEACAM1Antibody Market Report

Report Metric Details
Report Name CEACAM1Antibody Market
Accounted market size in 2023 US$ 394.6 million
Forecasted market size in 2030 US$ 894.4 million
CAGR 12.4%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Monoclonal Antibody
  • Polyclonal Antibody
Segment by Application
  • Flow Cytometry
  • ELISA
  • Western Blot
  • Immunoprecipitation
  • Immunofluorescence
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sino Biological, Inc., Abcam, Thermo Fisher Scientific (China) Co., Ltd., Bio-Techne, BioLegend, LifeSpan BioSciences, Inc, Elabscience Biotechnology Inc., Boster Biological Technology, Merck, Wuhan Fine Biotech Co., Ltd., ProSci Incorporated, Abbexa
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of CEACAM1Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of CEACAM1Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is CEACAM1Antibody Market growing?

Ans: The CEACAM1Antibody Market witnessing a CAGR of 12.4% during the forecast period 2024-2030.

What is the CEACAM1Antibody Market size in 2030?

Ans: The CEACAM1Antibody Market size in 2030 will be US$ 894.4 million.

Who are the main players in the CEACAM1Antibody Market report?

Ans: The main players in the CEACAM1Antibody Market are Sino Biological, Inc., Abcam, Thermo Fisher Scientific (China) Co., Ltd., Bio-Techne, BioLegend, LifeSpan BioSciences, Inc, Elabscience Biotechnology Inc., Boster Biological Technology, Merck, Wuhan Fine Biotech Co., Ltd., ProSci Incorporated, Abbexa

What are the Application segmentation covered in the CEACAM1Antibody Market report?

Ans: The Applications covered in the CEACAM1Antibody Market report are Flow Cytometry, ELISA, Western Blot, Immunoprecipitation, Immunofluorescence, Others

What are the Type segmentation covered in the CEACAM1Antibody Market report?

Ans: The Types covered in the CEACAM1Antibody Market report are Monoclonal Antibody, Polyclonal Antibody

1 CEACAM1Antibody Market Overview
1.1 Product Overview and Scope of CEACAM1Antibody
1.2 CEACAM1Antibody Segment by Type
1.2.1 Global CEACAM1Antibody Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 CEACAM1Antibody Segment by Application
1.3.1 Global CEACAM1Antibody Market Value by Application: (2024-2030)
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Others
1.4 Global CEACAM1Antibody Market Size Estimates and Forecasts
1.4.1 Global CEACAM1Antibody Revenue 2019-2030
1.4.2 Global CEACAM1Antibody Sales 2019-2030
1.4.3 Global CEACAM1Antibody Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 CEACAM1Antibody Market Competition by Manufacturers
2.1 Global CEACAM1Antibody Sales Market Share by Manufacturers (2019-2024)
2.2 Global CEACAM1Antibody Revenue Market Share by Manufacturers (2019-2024)
2.3 Global CEACAM1Antibody Average Price by Manufacturers (2019-2024)
2.4 Global CEACAM1Antibody Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CEACAM1Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CEACAM1Antibody, Product Type & Application
2.7 CEACAM1Antibody Market Competitive Situation and Trends
2.7.1 CEACAM1Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CEACAM1Antibody Players Market Share by Revenue
2.7.3 Global CEACAM1Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CEACAM1Antibody Retrospective Market Scenario by Region
3.1 Global CEACAM1Antibody Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global CEACAM1Antibody Global CEACAM1Antibody Sales by Region: 2019-2030
3.2.1 Global CEACAM1Antibody Sales by Region: 2019-2024
3.2.2 Global CEACAM1Antibody Sales by Region: 2025-2030
3.3 Global CEACAM1Antibody Global CEACAM1Antibody Revenue by Region: 2019-2030
3.3.1 Global CEACAM1Antibody Revenue by Region: 2019-2024
3.3.2 Global CEACAM1Antibody Revenue by Region: 2025-2030
3.4 North America CEACAM1Antibody Market Facts & Figures by Country
3.4.1 North America CEACAM1Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America CEACAM1Antibody Sales by Country (2019-2030)
3.4.3 North America CEACAM1Antibody Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe CEACAM1Antibody Market Facts & Figures by Country
3.5.1 Europe CEACAM1Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe CEACAM1Antibody Sales by Country (2019-2030)
3.5.3 Europe CEACAM1Antibody Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CEACAM1Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific CEACAM1Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific CEACAM1Antibody Sales by Country (2019-2030)
3.6.3 Asia Pacific CEACAM1Antibody Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CEACAM1Antibody Market Facts & Figures by Country
3.7.1 Latin America CEACAM1Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America CEACAM1Antibody Sales by Country (2019-2030)
3.7.3 Latin America CEACAM1Antibody Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CEACAM1Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa CEACAM1Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa CEACAM1Antibody Sales by Country (2019-2030)
3.8.3 Middle East and Africa CEACAM1Antibody Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CEACAM1Antibody Sales by Type (2019-2030)
4.1.1 Global CEACAM1Antibody Sales by Type (2019-2024)
4.1.2 Global CEACAM1Antibody Sales by Type (2025-2030)
4.1.3 Global CEACAM1Antibody Sales Market Share by Type (2019-2030)
4.2 Global CEACAM1Antibody Revenue by Type (2019-2030)
4.2.1 Global CEACAM1Antibody Revenue by Type (2019-2024)
4.2.2 Global CEACAM1Antibody Revenue by Type (2025-2030)
4.2.3 Global CEACAM1Antibody Revenue Market Share by Type (2019-2030)
4.3 Global CEACAM1Antibody Price by Type (2019-2030)
5 Segment by Application
5.1 Global CEACAM1Antibody Sales by Application (2019-2030)
5.1.1 Global CEACAM1Antibody Sales by Application (2019-2024)
5.1.2 Global CEACAM1Antibody Sales by Application (2025-2030)
5.1.3 Global CEACAM1Antibody Sales Market Share by Application (2019-2030)
5.2 Global CEACAM1Antibody Revenue by Application (2019-2030)
5.2.1 Global CEACAM1Antibody Revenue by Application (2019-2024)
5.2.2 Global CEACAM1Antibody Revenue by Application (2025-2030)
5.2.3 Global CEACAM1Antibody Revenue Market Share by Application (2019-2030)
5.3 Global CEACAM1Antibody Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sino Biological, Inc.
6.1.1 Sino Biological, Inc. Corporation Information
6.1.2 Sino Biological, Inc. Description and Business Overview
6.1.3 Sino Biological, Inc. CEACAM1Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sino Biological, Inc. CEACAM1Antibody Product Portfolio
6.1.5 Sino Biological, Inc. Recent Developments/Updates
6.2 Abcam
6.2.1 Abcam Corporation Information
6.2.2 Abcam Description and Business Overview
6.2.3 Abcam CEACAM1Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abcam CEACAM1Antibody Product Portfolio
6.2.5 Abcam Recent Developments/Updates
6.3 Thermo Fisher Scientific (China) Co., Ltd.
6.3.1 Thermo Fisher Scientific (China) Co., Ltd. Corporation Information
6.3.2 Thermo Fisher Scientific (China) Co., Ltd. Description and Business Overview
6.3.3 Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Product Portfolio
6.3.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
6.4 Bio-Techne
6.4.1 Bio-Techne Corporation Information
6.4.2 Bio-Techne Description and Business Overview
6.4.3 Bio-Techne CEACAM1Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio-Techne CEACAM1Antibody Product Portfolio
6.4.5 Bio-Techne Recent Developments/Updates
6.5 BioLegend
6.5.1 BioLegend Corporation Information
6.5.2 BioLegend Description and Business Overview
6.5.3 BioLegend CEACAM1Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BioLegend CEACAM1Antibody Product Portfolio
6.5.5 BioLegend Recent Developments/Updates
6.6 LifeSpan BioSciences, Inc
6.6.1 LifeSpan BioSciences, Inc Corporation Information
6.6.2 LifeSpan BioSciences, Inc Description and Business Overview
6.6.3 LifeSpan BioSciences, Inc CEACAM1Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LifeSpan BioSciences, Inc CEACAM1Antibody Product Portfolio
6.6.5 LifeSpan BioSciences, Inc Recent Developments/Updates
6.7 Elabscience Biotechnology Inc.
6.6.1 Elabscience Biotechnology Inc. Corporation Information
6.6.2 Elabscience Biotechnology Inc. Description and Business Overview
6.6.3 Elabscience Biotechnology Inc. CEACAM1Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elabscience Biotechnology Inc. CEACAM1Antibody Product Portfolio
6.7.5 Elabscience Biotechnology Inc. Recent Developments/Updates
6.8 Boster Biological Technology
6.8.1 Boster Biological Technology Corporation Information
6.8.2 Boster Biological Technology Description and Business Overview
6.8.3 Boster Biological Technology CEACAM1Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Boster Biological Technology CEACAM1Antibody Product Portfolio
6.8.5 Boster Biological Technology Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck CEACAM1Antibody Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Merck CEACAM1Antibody Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Wuhan Fine Biotech Co., Ltd.
6.10.1 Wuhan Fine Biotech Co., Ltd. Corporation Information
6.10.2 Wuhan Fine Biotech Co., Ltd. Description and Business Overview
6.10.3 Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Product Portfolio
6.10.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
6.11 ProSci Incorporated
6.11.1 ProSci Incorporated Corporation Information
6.11.2 ProSci Incorporated CEACAM1Antibody Description and Business Overview
6.11.3 ProSci Incorporated CEACAM1Antibody Sales, Revenue and Gross Margin (2019-2024)
6.11.4 ProSci Incorporated CEACAM1Antibody Product Portfolio
6.11.5 ProSci Incorporated Recent Developments/Updates
6.12 Abbexa
6.12.1 Abbexa Corporation Information
6.12.2 Abbexa CEACAM1Antibody Description and Business Overview
6.12.3 Abbexa CEACAM1Antibody Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Abbexa CEACAM1Antibody Product Portfolio
6.12.5 Abbexa Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CEACAM1Antibody Industry Chain Analysis
7.2 CEACAM1Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CEACAM1Antibody Production Mode & Process
7.4 CEACAM1Antibody Sales and Marketing
7.4.1 CEACAM1Antibody Sales Channels
7.4.2 CEACAM1Antibody Distributors
7.5 CEACAM1Antibody Customers
8 CEACAM1Antibody Market Dynamics
8.1 CEACAM1Antibody Industry Trends
8.2 CEACAM1Antibody Market Drivers
8.3 CEACAM1Antibody Market Challenges
8.4 CEACAM1Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bio-Techne
BioLegend
Lifespan Biosciences Inc.
Elabscience Biotechnology Inc.
Wuhan Fine Biotech Co.,Ltd.
ProSci Incorporated
Abbexa
Boster Biological Technology
Merck
Sino Biological Inc
Thermo Fisher Scientific (China) Co., Ltd.
Abcam
List of Tables
    Table 1. Global CEACAM1Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global CEACAM1Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global CEACAM1Antibody Market Competitive Situation by Manufacturers in 2023
    Table 4. Global CEACAM1Antibody Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global CEACAM1Antibody Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global CEACAM1Antibody Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global CEACAM1Antibody Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market CEACAM1Antibody Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of CEACAM1Antibody, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of CEACAM1Antibody, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of CEACAM1Antibody, Product Type & Application
    Table 12. Global Key Manufacturers of CEACAM1Antibody, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global CEACAM1Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CEACAM1Antibody as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global CEACAM1Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global CEACAM1Antibody Sales by Region (2019-2024) & (K Units)
    Table 18. Global CEACAM1Antibody Sales Market Share by Region (2019-2024)
    Table 19. Global CEACAM1Antibody Sales by Region (2025-2030) & (K Units)
    Table 20. Global CEACAM1Antibody Sales Market Share by Region (2025-2030)
    Table 21. Global CEACAM1Antibody Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global CEACAM1Antibody Revenue Market Share by Region (2019-2024)
    Table 23. Global CEACAM1Antibody Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global CEACAM1Antibody Revenue Market Share by Region (2025-2030)
    Table 25. North America CEACAM1Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America CEACAM1Antibody Sales by Country (2019-2024) & (K Units)
    Table 27. North America CEACAM1Antibody Sales by Country (2025-2030) & (K Units)
    Table 28. North America CEACAM1Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America CEACAM1Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe CEACAM1Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe CEACAM1Antibody Sales by Country (2019-2024) & (K Units)
    Table 32. Europe CEACAM1Antibody Sales by Country (2025-2030) & (K Units)
    Table 33. Europe CEACAM1Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe CEACAM1Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific CEACAM1Antibody Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific CEACAM1Antibody Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific CEACAM1Antibody Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific CEACAM1Antibody Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific CEACAM1Antibody Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America CEACAM1Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America CEACAM1Antibody Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America CEACAM1Antibody Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America CEACAM1Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America CEACAM1Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa CEACAM1Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa CEACAM1Antibody Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa CEACAM1Antibody Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa CEACAM1Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa CEACAM1Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global CEACAM1Antibody Sales (K Units) by Type (2019-2024)
    Table 51. Global CEACAM1Antibody Sales (K Units) by Type (2025-2030)
    Table 52. Global CEACAM1Antibody Sales Market Share by Type (2019-2024)
    Table 53. Global CEACAM1Antibody Sales Market Share by Type (2025-2030)
    Table 54. Global CEACAM1Antibody Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global CEACAM1Antibody Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global CEACAM1Antibody Revenue Market Share by Type (2019-2024)
    Table 57. Global CEACAM1Antibody Revenue Market Share by Type (2025-2030)
    Table 58. Global CEACAM1Antibody Price (US$/Unit) by Type (2019-2024)
    Table 59. Global CEACAM1Antibody Price (US$/Unit) by Type (2025-2030)
    Table 60. Global CEACAM1Antibody Sales (K Units) by Application (2019-2024)
    Table 61. Global CEACAM1Antibody Sales (K Units) by Application (2025-2030)
    Table 62. Global CEACAM1Antibody Sales Market Share by Application (2019-2024)
    Table 63. Global CEACAM1Antibody Sales Market Share by Application (2025-2030)
    Table 64. Global CEACAM1Antibody Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global CEACAM1Antibody Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global CEACAM1Antibody Revenue Market Share by Application (2019-2024)
    Table 67. Global CEACAM1Antibody Revenue Market Share by Application (2025-2030)
    Table 68. Global CEACAM1Antibody Price (US$/Unit) by Application (2019-2024)
    Table 69. Global CEACAM1Antibody Price (US$/Unit) by Application (2025-2030)
    Table 70. Sino Biological, Inc. Corporation Information
    Table 71. Sino Biological, Inc. Description and Business Overview
    Table 72. Sino Biological, Inc. CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Sino Biological, Inc. CEACAM1Antibody Product
    Table 74. Sino Biological, Inc. Recent Developments/Updates
    Table 75. Abcam Corporation Information
    Table 76. Abcam Description and Business Overview
    Table 77. Abcam CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Abcam CEACAM1Antibody Product
    Table 79. Abcam Recent Developments/Updates
    Table 80. Thermo Fisher Scientific (China) Co., Ltd. Corporation Information
    Table 81. Thermo Fisher Scientific (China) Co., Ltd. Description and Business Overview
    Table 82. Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Product
    Table 84. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
    Table 85. Bio-Techne Corporation Information
    Table 86. Bio-Techne Description and Business Overview
    Table 87. Bio-Techne CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Bio-Techne CEACAM1Antibody Product
    Table 89. Bio-Techne Recent Developments/Updates
    Table 90. BioLegend Corporation Information
    Table 91. BioLegend Description and Business Overview
    Table 92. BioLegend CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. BioLegend CEACAM1Antibody Product
    Table 94. BioLegend Recent Developments/Updates
    Table 95. LifeSpan BioSciences, Inc Corporation Information
    Table 96. LifeSpan BioSciences, Inc Description and Business Overview
    Table 97. LifeSpan BioSciences, Inc CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. LifeSpan BioSciences, Inc CEACAM1Antibody Product
    Table 99. LifeSpan BioSciences, Inc Recent Developments/Updates
    Table 100. Elabscience Biotechnology Inc. Corporation Information
    Table 101. Elabscience Biotechnology Inc. Description and Business Overview
    Table 102. Elabscience Biotechnology Inc. CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Elabscience Biotechnology Inc. CEACAM1Antibody Product
    Table 104. Elabscience Biotechnology Inc. Recent Developments/Updates
    Table 105. Boster Biological Technology Corporation Information
    Table 106. Boster Biological Technology Description and Business Overview
    Table 107. Boster Biological Technology CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Boster Biological Technology CEACAM1Antibody Product
    Table 109. Boster Biological Technology Recent Developments/Updates
    Table 110. Merck Corporation Information
    Table 111. Merck Description and Business Overview
    Table 112. Merck CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Merck CEACAM1Antibody Product
    Table 114. Merck Recent Developments/Updates
    Table 115. Wuhan Fine Biotech Co., Ltd. Corporation Information
    Table 116. Wuhan Fine Biotech Co., Ltd. Description and Business Overview
    Table 117. Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Product
    Table 119. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
    Table 120. ProSci Incorporated Corporation Information
    Table 121. ProSci Incorporated Description and Business Overview
    Table 122. ProSci Incorporated CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. ProSci Incorporated CEACAM1Antibody Product
    Table 124. ProSci Incorporated Recent Developments/Updates
    Table 125. Abbexa Corporation Information
    Table 126. Abbexa Description and Business Overview
    Table 127. Abbexa CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Abbexa CEACAM1Antibody Product
    Table 129. Abbexa Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. CEACAM1Antibody Distributors List
    Table 133. CEACAM1Antibody Customers List
    Table 134. CEACAM1Antibody Market Trends
    Table 135. CEACAM1Antibody Market Drivers
    Table 136. CEACAM1Antibody Market Challenges
    Table 137. CEACAM1Antibody Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of CEACAM1Antibody
    Figure 2. Global CEACAM1Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global CEACAM1Antibody Market Share by Type in 2023 & 2030
    Figure 4. Monoclonal Antibody Product Picture
    Figure 5. Polyclonal Antibody Product Picture
    Figure 6. Global CEACAM1Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global CEACAM1Antibody Market Share by Application in 2023 & 2030
    Figure 8. Flow Cytometry
    Figure 9. ELISA
    Figure 10. Western Blot
    Figure 11. Immunoprecipitation
    Figure 12. Immunofluorescence
    Figure 13. Others
    Figure 14. Global CEACAM1Antibody Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global CEACAM1Antibody Market Size (2019-2030) & (US$ Million)
    Figure 16. Global CEACAM1Antibody Sales (2019-2030) & (K Units)
    Figure 17. Global CEACAM1Antibody Average Price (US$/Unit) & (2019-2030)
    Figure 18. CEACAM1Antibody Report Years Considered
    Figure 19. CEACAM1Antibody Sales Share by Manufacturers in 2023
    Figure 20. Global CEACAM1Antibody Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest CEACAM1Antibody Players: Market Share by Revenue in 2023
    Figure 22. CEACAM1Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global CEACAM1Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America CEACAM1Antibody Sales Market Share by Country (2019-2030)
    Figure 25. North America CEACAM1Antibody Revenue Market Share by Country (2019-2030)
    Figure 26. United States CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe CEACAM1Antibody Sales Market Share by Country (2019-2030)
    Figure 29. Europe CEACAM1Antibody Revenue Market Share by Country (2019-2030)
    Figure 30. Germany CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific CEACAM1Antibody Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific CEACAM1Antibody Revenue Market Share by Region (2019-2030)
    Figure 37. China CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. China Taiwan CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America CEACAM1Antibody Sales Market Share by Country (2019-2030)
    Figure 45. Latin America CEACAM1Antibody Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa CEACAM1Antibody Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa CEACAM1Antibody Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE CEACAM1Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of CEACAM1Antibody by Type (2019-2030)
    Figure 55. Global Revenue Market Share of CEACAM1Antibody by Type (2019-2030)
    Figure 56. Global CEACAM1Antibody Price (US$/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of CEACAM1Antibody by Application (2019-2030)
    Figure 58. Global Revenue Market Share of CEACAM1Antibody by Application (2019-2030)
    Figure 59. Global CEACAM1Antibody Price (US$/Unit) by Application (2019-2030)
    Figure 60. CEACAM1Antibody Value Chain
    Figure 61. CEACAM1Antibody Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Carcinoembryonic Antigen related Cell Adhesion Molecule 5 CEACAM5 Antibody Market Research Report 2024
Global Carcinoembryonic Antigen related Cell Adhesion Molecule 5 CEACAM5 ELISA Kit Market Research Report 2024
Global DNAM 1 Antibody Market Research Report 2024
Global MUC1 Antibody Market Research Report 2024
Global CTLA 4 Antibody Market Research Report 2024
Global Histone Deacetylase 1 HDAC1 Antibody Market Research Report 2024
Global EpCAM Antibody Market Research Report 2024
Global VDAC1 Antibody Market Research Report 2024
Global CEA ELISA Kits Market Research Report 2024
Global Cyclin D1 Antibody Market Research Report 2024
Global Carcinoembryonic Antigen Quantitative Determination Kit Market Research Report 2024
Global BAG1 Antibody Market Research Report 2024
Global CEA Test Kits Market Research Report 2024
Global UBAP1 Antibody Market Research Report 2024
Global BCAM Antibody Market Research Report 2024
Global PECAM 1 Antibody Market Research Report 2024
Global Research Area Antibodies Market Research Report 2025
Global Mouse Antibody Market Research Report 2024
FABP1 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nuclear Antigen Antibody Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions